{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T13:29:03Z","timestamp":1789738143475,"version":"4.0.1"},"reference-count":89,"publisher":"Informa UK Limited","issue":"3","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Metabolism & Toxicology"],"published-print":{"date-parts":[[2018,3,4]]},"DOI":"10.1080\/17425255.2018.1432593","type":"journal-article","created":{"date-parts":[[2018,1,24]],"date-time":"2018-01-24T12:37:41Z","timestamp":1516797461000},"page":"317-330","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":25,"title":["Mitogen-activated protein kinase (MEK) inhibitors to treat melanoma alone or in combination with other kinase inhibitors"],"prefix":"10.1080","volume":"14","author":[{"given":"Elnaz","family":"Faghfuri","sequence":"first","affiliation":[{"name":"Pharmaceutical Biotechnology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shekoufeh","family":"Nikfar","sequence":"additional","affiliation":[{"name":"Department of Pharmacoeconomics and Pharmaceutical Administration, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran"},{"name":"Evidence-Based Medicine Group, Pharmaceutical Sciences Research Group, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamal","family":"Niaz","sequence":"additional","affiliation":[{"name":"International Campus, Tehran University of Medical Sciences, Tehran, Iran"},{"name":"Toxicology and Diseases Group, Pharmaceutical Sciences Research Group, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Ali","family":"Faramarzi","sequence":"additional","affiliation":[{"name":"Pharmaceutical Biotechnology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Abdollahi","sequence":"additional","affiliation":[{"name":"International Campus, Tehran University of Medical Sciences, Tehran, Iran"},{"name":"Toxicology and Diseases Group, Pharmaceutical Sciences Research Group, Tehran University of Medical Sciences, Tehran, Iran"},{"name":"Department of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2018,1,30]]},"reference":[{"key":"cit0001","author":"Tas F.","year":"2012","journal-title":"J Clin Oncol"},{"issue":"4","key":"cit0002","first-page":"572","volume":"7","author":"Sandru A","year":"2014","journal-title":"J Med Life"},{"key":"cit0003","author":"Ribas A.","year":"2015","journal-title":"J Clin Oncol"},{"key":"cit0004","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.ctrv.2007.06.004","volume":"33","author":"Lui P","year":"2007","journal-title":"Cancer Treat Rev"},{"issue":"5","key":"cit0005","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/CMR.0b013e3283649a97","volume":"23","author":"Teimouri F","year":"2013","journal-title":"Melanoma Res"},{"key":"cit0006","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1200\/JCO.1999.17.7.2105","volume":"17","author":"Atkins MB","year":"1999","journal-title":"J Clin Oncol"},{"key":"cit0007","doi-asserted-by":"crossref","first-page":"6681","DOI":"10.1158\/1078-0432.CCR-07-0187","volume":"13","author":"Downey SG","year":"2007","journal-title":"Clin Cancer Res"},{"key":"cit0008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/156720112798376069","volume":"9","author":"azirehi AR","year":"2012","journal-title":"Curr Drug Deliv"},{"key":"cit0009","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1007\/s40265-014-0314-5","volume":"74","author":"Poole RM","year":"2014","journal-title":"Drugs"},{"issue":"11","key":"cit0010","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.mpdhp.2014.10.001","volume":"20","author":"Naert K","year":"2014","journal-title":"Diagn Histopathol"},{"key":"cit0011","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12943-015-0293-5","volume":"14","author":"Atefi M","year":"2015","journal-title":"Mol Cancer"},{"issue":"16","key":"cit0012","doi-asserted-by":"crossref","first-page":"4014","DOI":"10.1002\/cncr.26724","volume":"118","author":"Jakob JA","year":"2012","journal-title":"Cancer"},{"key":"cit0013","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2147\/OTT.S39096","volume":"8","author":"Spagnolo F","year":"2015","journal-title":"Onco Targets Ther"},{"key":"cit0014","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/j.biopha.2017.09.088","volume":"95","author":"Yazdi MH","year":"2017","journal-title":"Biomed Pharmacother"},{"issue":"44","key":"cit0015","doi-asserted-by":"crossref","first-page":"78174","DOI":"10.18632\/oncotarget.19836","volume":"8","author":"Griffi M","year":"2017","journal-title":"Oncotarget"},{"key":"cit0016","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.ejca.2012.11.019","volume":"49","author":"Sullivan RJ","year":"2013","journal-title":"Eur J Cancer"},{"issue":"8","key":"cit0017","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1158\/1078-0432.CCR-13-2054","volume":"20","author":"Menzies AM","year":"2014","journal-title":"Clin Cancer Res"},{"key":"cit0018","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.coph.2015.05.012","volume":"23","author":"Templeton IE","year":"2015","journal-title":"Curr Opin Pharmacol"},{"issue":"39","key":"cit0019","doi-asserted-by":"crossref","first-page":"4724","DOI":"10.1038\/onc.2013.418","volume":"33","author":"Chen X","year":"2014","journal-title":"Oncogene"},{"issue":"3","key":"cit0020","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1158\/1535-7163.MCT-16-0552","volume":"16","author":"Cheng H","year":"2017","journal-title":"Mol Cancer Ther"},{"key":"cit0021","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3892\/or_00001020","volume":"24","author":"Zhou L","year":"2010","journal-title":"Oncol Rep"},{"issue":"1","key":"cit0022","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1756-8722-6-27","volume":"6","author":"Akinleye A","year":"2013","journal-title":"J Hematol Oncol"},{"issue":"1","key":"cit0023","doi-asserted-by":"crossref","first-page":"D1091","DOI":"10.1093\/nar\/gkt1068","volume":"42","author":"Law V","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"cit0024","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1056\/NEJMoa1210093","volume":"367","author":"Flaherty KT","year":"2012","journal-title":"N Engl J Med"},{"key":"cit0025","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S1470-2045(13)70237-7","volume":"14","author":"Robert C","year":"2013","journal-title":"Lancet Oncol"},{"key":"cit0026","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1158\/1078-0432.CCR-10-2200","volume":"17","author":"Gilmartin AG","year":"2011","journal-title":"Clin Cancer Res"},{"key":"cit0027","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nature04304","volume":"439","author":"Solit DB","year":"2006","journal-title":"Nature"},{"key":"cit0028","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S1470-2045(12)70269-3","volume":"13","author":"Falchook GS","year":"2012","journal-title":"Lancet Oncol"},{"issue":"2","key":"cit0029","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.cell.2009.12.040","volume":"140","author":"Heidorn SJ","year":"2010","journal-title":"Cell"},{"key":"cit0030","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S1470-2045(12)70270-X","volume":"13","author":"Infante JR","year":"2012","journal-title":"Lancet Oncol"},{"issue":"4","key":"cit0031","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1200\/JCO.2012.43.5966","volume":"31","author":"Kim KB","year":"2013","journal-title":"J ClinOncol"},{"key":"cit0032","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa1203421","volume":"367","author":"Flaherty KT","year":"2012","journal-title":"N Engl J Med"},{"key":"cit0033","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1056\/NEJMoa1406037","volume":"371","author":"Long GV","year":"2014","journal-title":"N Engl J Med"},{"key":"cit0034","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0140-6736(15)60898-4","volume":"386","author":"Long GV","year":"2015","journal-title":"Lancet"},{"key":"cit0035","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1056\/NEJMoa1412690","volume":"372","author":"Robert C","year":"2015","journal-title":"N Engl J Med"},{"issue":"5","key":"cit0036","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/nrc.2017.17","volume":"17","author":"Gotwals P","year":"2017","journal-title":"Nat Rev Cancer"},{"key":"cit0037","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.phrs.2017.07.006","volume":"123","author":"Pulluri B","year":"2017","journal-title":"Pharmacol Res"},{"key":"cit0038","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1200\/jco.2015.33.15_suppl.3003","volume":"33","author":"Ribas A","year":"2015","journal-title":"J Clin Oncol"},{"key":"cit0039","unstructured":"A study of the safety and efficacy of pembrolizumab (MK-3475) in combination with trametinib and dabrafenib in participants with advanced melanoma (MK-3475-022\/KEYNOTE-022). NCT02130466"},{"key":"cit0040","volume":"34","author":"Shoushtari AN","year":"2016","journal-title":"J Clin Oncol"},{"issue":"1","key":"cit0041","doi-asserted-by":"crossref","DOI":"10.1158\/0008-5472.CAN-11-1515","volume":"72","author":"Hoeflich KP","year":"2012","journal-title":"Cancer Res"},{"key":"cit0042","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1124\/dmd.111.043778","volume":"40","author":"Choo EF","year":"2012","journal-title":"Drug Metab Dispos"},{"issue":"8","key":"cit0043","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1158\/1538-7445.AM2011-1304","volume":"71","author":"Musib L","year":"2011","journal-title":"Cancer Res"},{"key":"cit0044","doi-asserted-by":"crossref","first-page":"4046","DOI":"10.1021\/mp400383x","volume":"10","author":"Musib L","year":"2013","journal-title":"Mol Pharm"},{"key":"cit0045","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1124\/dmd.115.066282","volume":"44","author":"Takahashi RH","year":"2016","journal-title":"Drug Metab Dispos"},{"key":"cit0046","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/S1470-2045(14)70301-8","volume":"15","author":"Ribas A","year":"2014","journal-title":"Lancet Oncol"},{"key":"cit0047","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1056\/NEJMoa1408868","volume":"371","author":"Larkin J","year":"2014","journal-title":"N Engl J Med"},{"issue":"15","key":"cit0048","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1200\/JCO.2017.35.15_suppl.3063","volume":"35","author":"Sullivan RJ","year":"2017","journal-title":"J Clin Oncol"},{"key":"cit0049","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1470-2045(13)70024-X","volume":"14","author":"Ascierto PA","year":"2013","journal-title":"Lancet Oncol"},{"key":"cit0050","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.ejca.2013.09.014","volume":"50","author":"Goldinger SM","year":"2014","journal-title":"Eur J Cancer"},{"issue":"15","key":"cit0051","first-page":"9009","volume":"32","author":"Sosman JA","year":"2014","journal-title":"ASCO Annu Meet Proc"},{"issue":"10","key":"cit0052","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.1073\/pnas.1216013110","volume":"110","author":"Posch C","year":"2013","journal-title":"Pnas"},{"issue":"12","key":"cit0053","doi-asserted-by":"crossref","first-page":"e28973","DOI":"10.1371\/journal.pone.0028973","volume":"6","author":"Atefi M","year":"2011","journal-title":"PLoS One"},{"issue":"15","key":"cit0054","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2014.58.2700","volume":"33","author":"Sullivan RJ","year":"2015","journal-title":"J Clin Oncol"},{"key":"cit0055","unstructured":"Study comparing combination of LGX818 plus MEK162 versus vemurafenib and LGX818 monotherapy in BRAF mutant melanoma (COLUMBUS). NCT01909453"},{"issue":"15","key":"cit0056","first-page":"TPS9102","volume":"32","author":"Flaherty K","year":"2014","journal-title":"ASCO Annu Meet Proc"},{"key":"cit0057","volume":"34","author":"Dummer R","year":"2016","journal-title":"J Clin Oncol"},{"key":"cit0058","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1158\/1535-7163.MCT-07-0231","volume":"6","author":"Davies BR","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"cit0059","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1158\/1078-0432.CCR-07-1440","volume":"14","author":"Haass NK","year":"2008","journal-title":"Clin Cancer Res"},{"key":"cit0060","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1158\/1078-0432.CCR-06-1150","volume":"13","author":"Yeh TC","year":"2007","journal-title":"Clin Cancer Res"},{"key":"cit0061","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1200\/JCO.2007.14.4956","volume":"26","author":"Adjei AA","year":"2008","journal-title":"J ClinOncol"},{"key":"cit0062","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1158\/1078-0432.CCR-09-2483","volume":"16","author":"Banerji U","year":"2010","journal-title":"Clin Cancer Res"},{"issue":"2","key":"cit0063","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1158\/1078-0432.CCR-11-1491","volume":"18","author":"Kirkwood JM","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"8","key":"cit0064","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1158\/1078-0432.CCR-12-3476","volume":"19","author":"Catalanotti F","year":"2013","journal-title":"Clin Cancer Res"},{"issue":"7","key":"cit0065","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/CAD.0b013e328350737d","volume":"23","author":"Boers-Sonderen MJ","year":"2012","journal-title":"Anti-Cancer Drugs"},{"issue":"9003","key":"cit0066","volume":"31","author":"Carvajal RD","year":"2013","journal-title":"J ClinOncol"},{"key":"cit0067","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1001\/jama.2014.6096","volume":"311","author":"Carvajal R","year":"2014","journal-title":"Jama"},{"issue":"5","key":"cit0068","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1038\/bjc.2012.8","volume":"106","author":"Holt SV","year":"2012","journal-title":"Br J Cancer"},{"issue":"4","key":"cit0069","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/cncr.27790","volume":"119","author":"Patel SP","year":"2013","journal-title":"Cancer"},{"issue":"21","key":"cit0070","doi-asserted-by":"crossref","first-page":"8736","DOI":"10.1158\/0008-5472.CAN-10-0902","volume":"70","author":"Gopal YN","year":"2010","journal-title":"Cancer Res"},{"issue":"4","key":"cit0071","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1073\/pnas.0811902106","volume":"106","author":"Chien AJ","year":"2009","journal-title":"Proc Nat lAcad Sci USA"},{"issue":"20","key":"cit0072","doi-asserted-by":"crossref","first-page":"3724","DOI":"10.4161\/cc.21645","volume":"11","author":"Conrad WH","year":"2012","journal-title":"Cell Cycle"},{"issue":"2607","key":"cit0073","volume":"34","author":"Janne PA","year":"2016","journal-title":"J Clin Oncol"},{"key":"cit0074","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1186\/s12885-015-1470-z","volume":"15","author":"Carvajal RD","year":"2015","journal-title":"BMC Cancer"},{"issue":"2","key":"cit0075","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1158\/0008-5472.CAN-10-3058","volume":"71","author":"Yoon J","year":"2011","journal-title":"Cancer Res"},{"issue":"15","key":"cit0076","volume":"32","author":"Massimini G","year":"2014","journal-title":"J ClinOncol"},{"issue":"15","key":"cit0077","first-page":"2530","volume":"31","author":"Heist RS","year":"2013","journal-title":"ASCO Annu Meet Proc"},{"issue":"6","key":"cit0078","first-page":"vi379","volume":"27","author":"Lebbe C","year":"2016","journal-title":"Ann Oncol"},{"key":"cit0079","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1126\/scisignal.2001948","volume":"4","author":"Poulikakos PI","year":"2011","journal-title":"Sci Signal"},{"issue":"7","key":"cit0080","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/annonc\/mdu169","volume":"25","author":"Urner-Bloch U","year":"2014","journal-title":"Ann Oncol"},{"key":"cit0081","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ophtha.2014.06.041","volume":"122","author":"Elon HC","year":"2015","journal-title":"Ophthalmology"},{"issue":"9","key":"cit0082","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1586\/14737140.2015.1074862","volume":"15","author":"Faghfuri E","year":"2015","journal-title":"Expert Rev Anticancer Ther"},{"key":"cit0083","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s11912-016-0531-z","volume":"18","author":"Reddy SM","year":"2016","journal-title":"Curr Oncol Rep"},{"key":"cit0084","author":"Luke JJ","year":"2017","journal-title":"Clin Oncol"},{"issue":"4","key":"cit0085","first-page":"mdu438","volume":"25","author":"Van Herpen C","year":"2014","journal-title":"Ann Oncol"},{"issue":"10","key":"cit0086","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1080\/17460441.2016.1217196","volume":"11","author":"Safavi M","year":"2016","journal-title":"Expert Opin Drug Discov"},{"key":"cit0087","unstructured":"Dabrafenib and trametinib followed by ipilimumab and nivolumab or ipilimumab and nivolumab followed by dabrafenib and trametinib in treating patients with stage III-IV BRAFV600 melanoma. NCT02224781"},{"key":"cit0088","unstructured":"Dabrafenib and trametinib in treating patients with stage III-IV BRAF mutant melanoma that cannot be removed by surgery. NCT02196181"},{"issue":"7","key":"cit0089","first-page":"451","volume":"13","author":"Gibney GT","year":"2015","journal-title":"Clin Adv Hematol Oncol"}],"container-title":["Expert Opinion on Drug Metabolism & Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17425255.2018.1432593","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T03:27:07Z","timestamp":1660361227000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17425255.2018.1432593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,30]]},"references-count":89,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3,4]]}},"alternative-id":["10.1080\/17425255.2018.1432593"],"URL":"https:\/\/doi.org\/10.1080\/17425255.2018.1432593","relation":{},"ISSN":["1742-5255","1744-7607"],"issn-type":[{"value":"1742-5255","type":"print"},{"value":"1744-7607","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,30]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iemt20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iemt20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2017-01-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-01-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-01-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}